2月27日，澜起科技盘中下跌2.00%，截至11:25，报161.81元/股，成交25.99亿元，换手率1.39%，总市 值1977.64亿元。 资金流向方面，主力资金净流出3.43亿元，特大单买入2.84亿元，占比10.93%，卖出4.76亿元，占比 18.32%；大单买入7.60亿元，占比29.25%，卖出9.11亿元，占比35.05%。 澜起科技今年以来股价涨37.36%，近5个交易日跌3.75%，近20日跌3.63%，近60日涨39.14%。 资料显示，澜起科技股份有限公司位于上海市徐汇区漕宝路181号和光天地16层,香港铜锣湾希慎道33号 利园1期19楼1918室，成立日期2004年5月27日，上市日期2019年7月22日，公司主营业务涉及澜起科技 股份有限公司是一家主要从事数据处理及互连芯片设计的中国公司。该公司主要包括两大产品线，互连 类芯片产品线和津逮服务器平臺产品线。互连类芯片产品包括内存接口芯片、内存模组配套芯片、PCIe Retimer芯片、MXC芯片、时钟芯片等。津逮服务器平臺产品包括津逮服务器中央处理器（CPU）、数 据保护、可信计算加速芯片和混合安全内存模组。该公司产品销往国内市场 ...

Core Viewpoint - The company, Shenzhen SanTai E-commerce Co., Ltd., is experiencing growth in its cross-border e-commerce business, benefiting from the depreciation of the RMB and advancements in AI technology for operational efficiency [2][4]. Group 1: Company Overview - Shenzhen SanTai E-commerce Co., Ltd. was established on January 7, 2008, and went public on September 28, 2023. Its main business includes cross-border e-commerce retail and logistics [8]. - The company's revenue composition is as follows: 76.14% from cross-border e-commerce product sales, 23.80% from logistics services, 0.04% from technical services, and 0.02% from other business [8]. - As of February 26, the company's market capitalization is 7.344 billion yuan, with a trading volume of 183 million yuan and a turnover rate of 8.94% [1]. Group 2: Financial Performance - For the period from January to September 2025, the company achieved a revenue of 1.252 billion yuan, reflecting a year-on-year growth of 0.15%. However, the net profit attributable to shareholders decreased by 25.94% to 31.8471 million yuan [9]. - The company's overseas revenue accounts for 99.98% of its total revenue, benefiting from the depreciation of the RMB [4]. Group 3: Technological Innovations - The company is developing an AIGC project that utilizes Stable Diffusion to generate high-quality images, enhancing operational efficiency and reducing production costs [2]. - The launch of the "RuiGuan AI Assistant," an AI tool for cross-border infringement detection, aims to provide efficient compliance solutions for cross-border sellers and operators [2][3]. - The company has trained a multimodal model named "RuiGuan · ERiC" to offer product risk detection services for cross-border e-commerce enterprises [3]. Group 4: Market Dynamics - The stock has seen a net inflow of 19.3736 million yuan today, with a significant decrease in net inflow over the past three days [5][6]. - The average trading cost of the stock is 9.33 yuan, with the current price near a support level of 9.23 yuan [7].

2、百奥赛图(北京)医药科技股份有限公司于2025-12-10上市，公司主营业务为从事提供基因编辑服务、 临床前药理药效评估服务、模式动物销售、抗体开发及创新药开发。 3、百奥赛图(北京)医药科技股份有限公司是一家主要从事药物开发业务及临床前研究的公司。该公司 通过五个分部开展业务。 来源：新浪证券-红岸工作室 2月26日，百奥赛图涨8.15%，成交额2.11亿元，换手率7.92%，总市值346.39亿元。 异动分析 AI智能体+科创次新股+CRO概念+人民币贬值受益+注册制次新股 1、2026年1月13日互动易：我们通过AI的本地化部署，正在建设抗体药物研发AI智能体。随着千鼠万 抗计划与AI系统深度整合的持续推进，我们将为全球药企提供更加高效的研发工具和更为丰富的抗体 分子库，帮助药企伙伴提高临床前PCC分子的研发效率，这也将推动抗体发现业务迈入全新发展阶段。 区间今日近3日近5日近10日近20日主力净流入218.42万-921.89万-975.39万2306.19万7132.04万 公司简介 4、根据2024年年报，公司海外营收占比为67.94%，受益于人民币贬值。 5、百奥赛图(北京)医药科技股份有限 ...

来源：新浪证券-红岸工作室 2、根据2024年年报，公司海外营收占比为69.12%，受益于人民币贬值。 3、专精特新"小巨人"企业是全国中小企业评定工作中最高等级、最具权威的荣誉称号，是指专注于细 分市场、创新能力强、市场占有率高、掌握关键核心技术、质量效益优的排头兵企业，对于提升中小企 业自身的竞争力，以及提升产业链、供应链稳定性和竞争力具有重大意义。公司已入选工信部专精特新 小巨人企业名单。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 资金分析 2月26日，海泰新光跌0.68%，成交额5012.81万元，换手率0.89%，总市值55.75亿元。 今日主力净流入-525.79万，占比0.1%，行业排名96/138，该股当前无连续增减仓现象，主力趋势不明 显；所属行业主力净流入-6.67亿，连续3日被主力资金减仓。 异动分析 区间今日近3日近5日近10日近20日主力净流入-525.79万-850.63万-1765.79万-876.82万-4068.79万 医疗器械概念+人民币贬值受益+专精特新 主力持仓 1、公司始终致力于将光学技术与医疗器械行业的前沿应用趋势相结合，研究 ...

Core Viewpoint - Suzhou Zhongjie Automotive Parts Co., Ltd. has shown a significant increase in stock price and trading volume, indicating positive market sentiment and potential growth opportunities in the automotive thermal management sector. Group 1: Company Overview - Suzhou Zhongjie Automotive Parts Co., Ltd. specializes in the research, production, and sales of precision components for automotive thermal management systems, with main products including automotive air conditioning heat exchangers, oil coolers, heat pump systems, and battery coolers [3][7]. - The company was established on February 10, 2010, and went public on April 25, 2025 [7]. - As of January 9, 2025, the company had 9,614 shareholders, with an average of 2,529 circulating shares per person, reflecting a slight decrease in shareholder numbers [7]. Group 2: Financial Performance - For the period from January to September 2025, the company achieved a revenue of 809 million yuan, representing a year-on-year growth of 11.68%, while the net profit attributable to the parent company was 61.35 million yuan, a decrease of 9.46% year-on-year [7]. - The company has distributed a total of 9.73 million yuan in dividends since its A-share listing [8]. Group 3: Market Dynamics - The company's overseas revenue accounted for 78.17% of total revenue, benefiting from the depreciation of the RMB [3]. - The main business revenue composition is 89.17% from automotive thermal management systems and 10.83% from other sources [7]. Group 4: Technical Analysis - The average trading cost of the stock is 39.45 yuan, with the stock price approaching a resistance level of 43.14 yuan, suggesting potential for upward movement if this level is breached [6].

Core Viewpoint - The company, Slin Intelligent Drive, is experiencing growth in its core business areas, particularly in the production of harmonic reducers and components for humanoid robots, benefiting from the depreciation of the RMB and its recognition as a "specialized and innovative" small giant enterprise [2][3]. Group 1: Company Performance - As of September 30, 2025, Slin Intelligent Drive reported a revenue of 581 million yuan, representing a year-on-year growth of 4.38%, and a net profit attributable to shareholders of 140 million yuan, with a growth of 2.17% [7]. - The company has a total market capitalization of 39.647 billion yuan, with a trading volume of 641 million yuan and a turnover rate of 2.65% on February 26 [1]. - The company has distributed a total of 131 million yuan in dividends since its A-share listing [8]. Group 2: Product Development - The company is in the early stages of mass production for its harmonic reducers, which are essential for various robotic applications, including industrial and collaborative robots [2]. - Slin Intelligent Drive has successfully developed and mass-produced high-performance new products, such as low-energy consumption bearings and self-locking hub bearings, which are critical for electric vehicle drive systems [2][3]. Group 3: Market Position and Recognition - The company has achieved a significant overseas revenue share of 68.37%, benefiting from the depreciation of the RMB [3]. - Slin Intelligent Drive has been recognized as a national-level "specialized and innovative" small giant enterprise, which enhances its competitiveness and stability within the supply chain [3]. Group 4: Shareholder and Market Dynamics - As of September 30, 2025, the number of shareholders decreased by 13.12% to 14,700, while the average number of tradable shares per person increased by 14.92% to 6,615 shares [7]. - The main capital flow indicates a net outflow of 4.1209 million yuan, with the stock showing no clear trend in major capital movements [4][5].

2、根据2023年3月7日互动易，公司主要向消费电子、物联网、照明、工业及汽车领域等应用领域的电 子产品制造商销售电子元器件，并提供产品方案和技术支持，其中有部分产品为MCU芯片。 3、公司2023年5月5日公告：公司芯片定制业务芯片定制业务推出了"智能复位MCU"和"智能复位和高 速通信芯片"两款产品，主要应用于TWS耳机，已批量供货。 来源：新浪证券-红岸工作室 2月26日，好上好涨0.77%，成交额1.67亿元，换手率3.23%，总市值93.70亿元。 异动分析 存储芯片+MCU芯片+无线耳机+芯片概念+人民币贬值受益 1、2023年6月1日互动易回复：公司代理的产品主要包括SoC芯片、无线芯片及模块、电源及功率器 件、模拟/数字器件、存储器等主动元器件，存储器业务是公司主要业务的方向之一。 4、深圳市好上好信息科技股份有限公司的主营业务是电子元器件分销，主要向消费电子、物联网、照 明、工业控制、汽车电子及新能源等应用领域的电子产品制造商销售电子元器件，并提供相关产品设计 方案和技术支持等服务。主要产品包括SoC芯片、无线芯片及模块、电源及功率器件、模拟/数字器件、 存储器、LED器件、处理器、传感器、 ...

来源：新浪证券-红岸工作室 2月26日，天振股份跌1.46%，成交额8501.00万元，换手率6.22%，总市值54.02亿元。 异动分析 3D打印+人民币贬值受益+参股银行 1、2024年4月26日公告：公司在3D打印等新工艺上也已取得重大突破，通过3D打印技术在各类PVC地 板及PET地板上的应用，以获得更好的立体感效果，从而满足市场对地板产品性能多元化的需求，进一 步完善公司产品的覆盖面，提高公司的产品竞争力。 2、根据2024年年报，公司海外营收占比为98.25%，受益于人民币贬值。 3、2024年半年报：公司投资浙江安吉交银村镇银行股份有限公司期末余额5,000,000.00元。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 资金分析 今日主力净流入-354.28万，占比0.04%，行业排名51/75，连续2日被主力资金减仓；所属行业主力净流 入-1.63亿，连续2日被主力资金减仓。 区间今日近3日近5日近10日近20日主力净流入-354.28万-1717.20万-1884.26万-2038.07万-2552.65万 主力持仓 主力没有控盘，筹码分布非常分散，主力 ...

Core Viewpoint - The company, Wuhan LianTe Technology Co., Ltd., specializes in the research, production, and sales of optical communication transceiver modules, with a significant focus on high-speed optical modules and related technologies. Company Overview - Wuhan LianTe Technology was established on October 28, 2011, and went public on September 13, 2022. The company is located in the East Lake New Technology Development Zone, Wuhan [7]. - The main business revenue composition includes 92.72% from optical modules of 10G and above, 5.57% from optical modules below 10G, and 1.71% from material sales and leasing [7]. Financial Performance - For the period from January to September 2025, the company achieved operating revenue of 847 million yuan, representing a year-on-year growth of 31.75%. The net profit attributable to the parent company was 81.8 million yuan, with a year-on-year increase of 31.39% [8]. - The company has distributed a total of 46.85 million yuan in dividends since its A-share listing [8]. Market Position and Technology - The company possesses core capabilities in the design and manufacturing of optical chips and devices, focusing on high-speed optical modules and technologies such as EML, SIP, and TFLN modulation [2]. - The primary application markets for optical modules include data communication, telecommunications, and emerging markets, with the data communication market being the fastest-growing segment [2][3]. - The company's low-power design technology for optical modules significantly reduces power consumption, providing a competitive advantage in 5G communication and data center applications [3]. Shareholder and Market Activity - As of September 30, 2025, the number of shareholders increased to 24,900, with an average of 2,725 circulating shares per person, a decrease of 6.66% from the previous period [8]. - The company has seen changes in its major shareholders, with Hong Kong Central Clearing Limited being the fourth largest shareholder, increasing its holdings by 533,300 shares [8].

Core Viewpoint - Zhonghong Medical is focusing on innovation and digital technology integration to develop high-performance medical products, aiming to become a leading provider of intelligent medical solutions in the industry [2]. Group 1: Company Overview - Zhonghong Medical is primarily engaged in the research, production, and sales of high-quality disposable protective gloves, with a revenue composition of 89.48% from health protection products, 6.22% from safety infusion products, and 4.30% from innovative incubation products [9]. - The company was established on December 22, 2010, and went public on April 27, 2021 [9]. - As of September 30, 2025, Zhonghong Medical reported a revenue of 1.864 billion yuan, representing a year-on-year growth of 1.38%, while the net profit attributable to shareholders was -7.21 million yuan, a decrease of 114.13% year-on-year [10]. Group 2: Market Position and Financials - The company has a significant overseas revenue share of 81.56%, benefiting from the depreciation of the RMB [4]. - Zhonghong Medical operates as a state-owned enterprise, with its ultimate control held by the Xiamen Municipal Government State-owned Assets Supervision and Administration Commission [5]. - The stock has seen a net outflow of 4.3763 million yuan today, with a continuous reduction in main funds over the past three days [6][7]. Group 3: Product Highlights - At the 12th Beijing Pet Expo, Zhonghong Medical showcased its innovative veterinary infusion pumps, which feature IP34 waterproof design and dual CPU architecture, providing multiple infusion modes and safety features [3]. - The infusion pumps are designed for ease of use and adaptability in various clinical settings, enhancing the safety and precision of fluid administration [3]. Group 4: Shareholder Information - As of September 30, 2025, the number of shareholders increased to 22,400, with an average of 17,531 circulating shares per person, a decrease of 10.11% from the previous period [10]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited and a medical device ETF, indicating a diverse shareholder base [11].